<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">

    <title type="text">Culture Making Articles items tagged cancer</title>
    <subtitle type="text">Culture Making Articles:Writing on Christianity and culture from Andy Crouch</subtitle>
    <link rel="alternate" type="text/html" href="http://culture-makers.com/" />
    <link rel="self" type="application/atom+xml" href="https://culture-making.com/tag/atom" />
    <updated>2025-01-03T22:54:05Z</updated>
    <rights>Copyright (c) 2025, Andy Crouch</rights>
    <generator uri="http://www.pmachine.com/" version="7.5.15">ExpressionEngine</generator>
    <id>tag:culture-makers.com,2025:01:02</id>

    <entry>
      <title>Cancer study fail</title>
      <link rel="alternate" type="text/html" href="https://culture-making.com/post/cancer_study_fail" />
      <id>tag:culture-makers.com,2025:author/1.883</id>
      <published>2025-01-02T22:53:00Z</published>
      <updated>2025-01-03T22:54:05Z</updated>
      <author>
            <name>Andy Crouch</name>
            <email>andy@culture-making.com</email>
            
      </author>

      <content type="html"><![CDATA[
        
			
			
			

			<b><p>Nate</p>: </b><em>?There must be a culturally-creative way around this sticking point of human (and corporate) nature. Required reporting, as with industrial accidents? Anonymous publication? A Nobel Prize for the best idea that didn't pan out??</em><br />

<div class="author" style="font-size: -1">"<a href="http://ideas.blogs.nytimes.com/2008/09/26/fewer-than-1-in-5-cancer-trials-published/">Fewer Than 1 in 5 Cancer Trials Published," <a href="http://ideas.blogs.nytimes.com/2008/09/26/fewer-than-1-in-5-cancer-trials-published/">NYTimes.com Ideas Blog</a>, 26 September 2008</div><hr />		
		<p><strong>Medicine |</strong> A <a href="http://www.theoncologist.com/cgi/reprint/theoncologist.2008-0133v1">medical journal</a> says a vast amount of cancer research is never published, perhaps because clinical trials show the drugs or treatments didn’t work. That deprives other researchers of valuable knowledge. Why this happens: scientists, medical journals and drug firms all have an interest in touting breakthroughs and not failure. [<a href="http://www.businessweek.com/technology/content/sep2008/tc20080925_035720.htm?campaign_id=rss_daily">Business Week</a>, <a href="http://www.theoncologist.com/cgi/reprint/theoncologist.2008-0133v1">Oncologist</a>]</p>
		
	
			
			
			

		
      ]]></content>
    </entry>

</feed>